HomeDoctors

Dr Satyendra Katewa

Director – Hemato-Oncology & Bone Marrow Transplant, Paediatric Oncology

MBBS, DNB (Paediatrics), Fellowships in Paediatric Haemato-Oncology & BMT

Cancer (Oncology)

>

Paediatrics

>

January 1, 1998

Top Areas of Expertise

  • Paediatric Haemato-Oncology
  • Bone Marrow Transplant (Autologous & Allogeneic)
  • Immunodeficiency Disorders
  • Thalassemia, Aplastic Anaemia, and Hemophilia
  • Leukaemia (ALL, AML) and Lymphoma (Hodgkin, Non-Hodgkin)

Top Treatments Offered

  • Bone Marrow Transplant (Autologous, Allogeneic, Haploidentical)
  • Treatment of Leukaemia and Lymphoma in Children
  • Management of Thalassemia, ITP, and Aplastic Anaemia
  • Immunotherapy for Paediatric Cancers
  • Cellular Therapy and Genetic Correction using CRISPR

About Dr Satyendra Katewa

Dr. Satyendra Katewa is a highly experienced Paediatric Haemato-Oncologist and BMT Specialist at Max Healthcare, Delhi NCR. With over two decades of experience, he has established expertise in managing complex cases of Leukaemia, Lymphoma, and rare immunodeficiency disorders. Trained internationally, including at the Hospital for Sick Children, Toronto, he is also an active researcher with multiple international publications in bone marrow transplantation and cellular therapy. His compassionate approach and scientific precision make him a trusted name in paediatric cancer care.

Educational Qualifications:

  • CRISPR Certification – Harvard University, USA (2020)
  • Fellowship (Paediatric Haemato-Oncology & BMT) – University of Toronto, Canada (2011)
  • Fellowship (Paediatric Haemato-Oncology & BMT) – Sir Ganga Ram Hospital, New Delhi (2009)
  • DNB (Paediatrics) – Sir Ganga Ram Hospital, New Delhi (2007)
  • MBBS – Sardar Patel Medical College, Bikaner (1998)

Professional Experience:

  • Dr Satyendra Katewa is currently working at Max Healthcare.
  • Director – Haemato-Oncology, Paediatric Oncology, BMT & Cellular Therapy, Shalby Sanar International Hospital, Gurugram (2024 - 2025)
  • HOD – Paediatric Haemato-Oncology, BMT, & Cellular Therapy, Manipal Hospital Dwarka, Delhi (2023 - 2024)
  • HOD – Paediatric Haemato-Oncology & Bone Marrow Transplant, Manipal Hospital, Jaipur, Rajasthan (2015 - 2023)
  • Consultant – Paediatric Haemato-Oncology & Bone Marrow Transplant, Fortis Memorial Research Institute, Gurgaon (2013 - 2015)
  • Clinical Associate – Bone Marrow Transplant Unit, Division of Paediatric Haemato- Oncology, Hospital for Sick Children “Sickkids”, Toronto, Canada (2012 - 2013)
  • Clinical Associate – Paediatric Haemato-Oncologist & BMT, Dr B.L. Kapoor Memorial Hospital, New Delhi (2009 - 2011)
  • Senior Registrar – Paediatric Haematology Oncology & Bone Marrow Transplant, Sir Ganga Ram Hospital, New Delhi (2006 - 2008)
  • Resident – Paediatrics, Sardar Patel Medical College, Bikaner (2001 - 2003)

Professional Memberships:

  • Rajasthan Medical Council
  • Delhi Medical Council
  • Indian Academy of Pediatrics (IAP)
  • Paediatric Hematology Oncology (PHO) Chapter of IAP
  • International Society of Paediatric Oncology (SIOP)
  • American Society of Paediatric Hemato-Oncology (ASPHO)
  • American Society of Bone Marrow Transplant (ASBMT)
  • European Society of Immunodeficiency Diseases (ESID)

Research Papers & Publications:

  • Publication on "Selection and Pre-Transplant Evaluation of Donor and Recipient in Haematopoietic Cell Transplantation", Textbook Contemporary Bone Marrow Transplantation
  • Publication on "Outcome of TCR αβ and CD19 Depletion Vs. Post-Transplant Cyclophosphamide Haploidentical Hematopoietic Stem Cell Transplant in patients with Thalassemia Major", A Comparative Analysis, European BMT Meeting 2025
  • Publication on “MRD negative CR after Azacitidine and Venetoclax in a young patient with AML, unfit for intensive induction followed by ASCT", Volume 16, Leukemia Research Reports
  • Publication on "Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide for Haemophagocytic Lymphohistiocytosis", Journal of Paediatric Haematology/Oncology
  • Publication on "Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse", Pediatric Blood & Cancer.
We are here to help you
Contact us for assistance

How we assist you at ?

Ensuring the best care for Bangladeshi patients is our top priority at mheco. We help you avail the following services at

Book Doctor Appointment
Get Treatment Cost
Visa Invitation Letter
Book Airport Pickup
Second Medical Opinion
Teleconsultation
Enquire Now
Book Hotel

Patient Testimonials

how patients worldwide trust hospitals in India for expert medical care.
No items found.

All Your Questions, Answered

No items found.